Mann in Geschäftskleidung mit Brille, dunklen Haaren und gemusterter Krawatte, lächelnd in einem Flur einer Anwaltskanzlei - er vertritt Anwälte in Chicago, die auf geistiges Eigentum spezialisiert sind.

Navid Fanaeian

Chefsyndikus

Navid Fanaeian is driven by his love of science and engineering to help clients achieve the full potential of their technologies. He counsels cutting-edge technology companies and world-renowned academic institutions, from startups to Fortune 50 companies, on strategic development of domestic and international patent portfolios. Through collaboration with scientists, engineers, and researchers, Navid regularly helps his clients look beyond the present impact of their technologies and better appreciate future possibilities.

Navid’s unique background combines electrical engineering and life sciences, making him peculiarly well suited for cross-disciplinary technologies that extend beyond traditional categories. His clients include companies and institutions developing computing-based solutions, such as through artificial intelligence and machine learning, to achieve revolutionary advances in countless fields. Navid works with clients in such areas as medical devices, including software as a medical device; drug discovery; health care delivery; medical imaging and image processing; bioinformatics and cheminformatics; noninvasive or minimally invasive diagnostics; oncology; genomics; microfluidics; autonomous driving; pathology; cybersecurity; augmented reality; Internet of Things (IoT); finance; and green technologies.

Präsentationen und Veröffentlichungen

  • Past Contributor, Patent Law Chapter, Wisconsin Attorney’s Desk Reference
September 13, 2024 Foley Viewpoints

German High Court Rules AI-Generated Inventions Can Receive Patent Protection

A recent decision by the German Bundesgerichtshof (Federal Court of Justice, 2024 June 11, no. X ZB 5/22) found that AI-generated...
Eine digitale Illustration eines menschlichen Gehirns mit mehrfarbigen neuronalen Netzen und Knoten, die neuronale Verbindungen und Hirnaktivität symbolisieren - eine künstlerische Anspielung auf die komplexen Überlegungen, die dem Recht des geistigen Eigentums zugrunde liegen.
11. Dezember 2023 Einblicke in innovative Technologien

KI im Gesundheitswesen: Bessere Behandlungsergebnisse für Patienten

Willkommen bei „KI im Gesundheitswesen: Bessere Behandlungsergebnisse für Patienten“. In diesem E-Book untersuchen unsere Autoren diese Schnittstelle unter verschiedenen Gesichtspunkten, darunter ihre Auswirkungen auf Fusionsaktivitäten, Kartellrechtsdurchsetzung, Patentverfolgung und vieles mehr.
A scientist wearing a virtual reality headset interacts with invisible controls in a laboratory, with lab equipment and a microscopic image visible in the background—highlighting technology’s growing role in intellectual property law and litigation support.
March 2, 2023 Health Care Law Today

Die Zukunft der KI im Gesundheitswesen: Neue Innovationsmöglichkeiten für den gesamten Gesundheitssektor

With the health care industry under pressure to improve patient outcomes while controlling costs, artificial intelligence and machine learning are quickly becoming indispensable tools
Eine Person sitzt an einem Schreibtisch in einer Anwaltskanzlei für Unternehmensrecht und nutzt zwei Computerbildschirme, auf denen Datenvisualisierungen und komplexe Diagramme in einer modernen Büroumgebung angezeigt werden.
July 22, 2021 Blogs

An Introduction to Patents

Obtaining patents for your technology can be crucial to gaining market share, maintaining competitive advantage, and securing the funding needed to establish and grow your business.
Digital illustration of multiple blue virus particles resembling coronaviruses on a dark blue background, ideal for Chicago lawyers or litigation support teams addressing legal challenges related to healthcare or public safety.
11. Mai 2020 Blogs

New USPTO Pilot Program to Expedite Grant of Small Entity COVID-19 Patents

In an effort to help independent inventors and small businesses bring “important and possibly life-saving treatments” to market more quickly, the USPTO is implementing the COVID-19 Prioritized Examination Pilot Program (“C-19 PEPP”).